MyAverix Finance
ST · Healthcare
Newbury Pharmaceuticals AB (NEWBRY)
Drug Manufacturers - Specialty & Generic
Newbury Pharmaceuticals AB (NEWBRY) is listed on ST in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for NEWBRY
Newbury Pharmaceuticals AB (NEWBRY) — FAQ
What is NEWBRY's P/E ratio?
The price-to-earnings (P/E) ratio for Newbury Pharmaceuticals AB (NEWBRY) is 18.00 (data as of 2026-05-23).
Does Newbury Pharmaceuticals AB pay a dividend?
Dividend yield is not available in the current snapshot for Newbury Pharmaceuticals AB (NEWBRY). Check the MyAverix Finance app for the latest dividend data.
What sector is Newbury Pharmaceuticals AB in?
Newbury Pharmaceuticals AB (NEWBRY) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is NEWBRY listed on?
NEWBRY is listed on ST.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.